Back to search

University of Sheffield

Understanding the metabolic impact of a multidrug resistant plasmid, pLL35, on diverse Escherichia coli lineages.

Abstract

dc:description.abstract

Antibiotic resistant infections are predicted to claim 10 million lives annually by 2050. Multi-drug resistant bacterial strains cause untreatable infections or necessitate lastline antibiotics. Conjugative plasmids carry resistance genes and facilitate the evolution of multidrug resistance by horizontal transfer of genetic material. Plasmids have complex interactions with their bacterial hosts that are not fully understood. Chapter 2 describes an analysis pipeline for untargeted metabolomics that was developed and published to make this complex methodology more accessible, then used throughout the thesis. This thesis explores the metabolic relationship between the multi-drug resistant plasmid pLL35 in diverse Escherichia coli strains across key stages: plasmid acquisition, subsequent coevolution and exposure to antibiotics. Chapter 3: Upon acquisition of the plasmid, metabolomics reveals strain specific alterations in functions such as ubiquinone biosynthesis, central energy production and amino acid biosynthesis. Chapter 4: 3 strains that had been experimentally evolved in previous work were compared to their ancestors and displayed metabolic alterations associated with adaptation to lab conditions; amino acid biosynthesis, glycolysis and pyrimidine biosynthesis. The strains had specific metabolic alterations according to evolutionary treatment (plasmid carrying with and without cefotaxime selection) with a singular exception: the global regulator cyclic AMP, which was consistently upregulated in plasmid carriers in response to antibiotic selection. Functions affected by coevolution and selection included amino acid biosynthesis, central energy production and stress responses. Chapter 5: 4 plasmid carrying strains are exposed to kanamycin, cefotaxime and ciprofloxacin. Common stress and resistance responses are observed, but responses at a pathway and metabolite level are strain specific in extent and direction of change. Pathways affected include amino acid and nucleotide metabolism, energy production, biosynthesis of cell wall and biofilm components and redox stress management, providing insights into bacterial stress responses and resistance mechanisms beyond plasmid-encoded genes. Thus, Escherichia coli adapt to plasmid carriage and antibiotic exposure by subtle alterations of its metabolism on a network wide scale.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Sheffield
Year dc:date.issued
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Billane, Kathryn Clare
Advisors dc:contributor.advisor
  • Harrison, Ellie
  • Cameron, Duncan
  • Brockhurst, Michael
ORCID person:identifier.orcid

Rights

Language dc:language.dcterms_iso639_2
eng

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Billane, Kathryn Clare. Understanding the metabolic impact of a multidrug resistant plasmid, pLL35, on diverse Escherichia coli lineages.. doctoral thesis, University of Sheffield, 2023.